Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-7022
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting ; volume:6 ; number:1 ; day:7 ; month:9 ; year:2016 ; pages:1-8 ; date:12.2016
Clinical and translational allergy ; 6, Heft 1 (7.9.2016), 1-8, 12.2016
- Urheber
-
Hahn-Pedersen, J.
- Beteiligte Personen und Organisationen
-
Worm, M.
Green, W.
Andreasen, J. Nørgaard
Taylor, M.
SpringerLink (Online service)
- DOI
-
10.1186/s13601-016-0127-6
- URN
-
urn:nbn:de:1111-201610064002
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hahn-Pedersen, J.
- Worm, M.
- Green, W.
- Andreasen, J. Nørgaard
- Taylor, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III
SQ ZET
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III
SQ ZET
A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
slit
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
SQ
"SQ"
SQ
SQ
SQ
Nachmeldg. Formblatt SQ I und SQ III